Sacituzumab govitecan shows survival benefit in endocrine-resistant hormone-positive metastatic breast cancer
Bookmark1. Median overall survival increased by 3.2 months in the sacituzumab govitecan group...
Read MoreNov 9, 2023
Bookmark1. Median overall survival increased by 3.2 months in the sacituzumab govitecan group...
Read MoreNov 8, 2023
Bookmark1. In this cross-sectional study, spiritual intelligence was a significant predictor of...
Read MoreNov 8, 2023
Bookmark1. Avacincaptad pegol significantly slowed geographic atrophy over 12 months. 2. Exudative...
Read MoreNov 8, 2023
Bookmark1. This cross-sectional study found that physical activity, employment, pain, and sense of...
Read MoreNov 7, 2023
Bookmark1. The progression-free survival was 24.8 months in the selpercatinib group vs 11.2 months in the control group (chemotherapy ± pembrolizumab), with an HR of 0.46. 2. Grade ≥3 adverse events occurred in 70% vs 57%...
Read MoreNov 1, 2023
Bookmark1. 30-day mortality was comparable among patients on VA-ECMO and medical therapy alone. 2....
Read MoreOct 31, 2023
Bookmark1. This randomized controlled trial found that children with obstructive sleep apnea...
Read MoreOct 31, 2023
Bookmark1. Median progression-free survival was 11.4 months in the amivantamab–chemotherapy group...
Read MoreOct 31, 2023
Bookmark1. Median overall survival and progression-free survival were greater in the tebentafusp...
Read MoreOct 26, 2023
Bookmark1. This analysis of a population-based cohort found that those who engaged in high and...
Read MoreOct 25, 2023
Bookmark1. In surveyed sample, parental hesitancy towards routine vaccination during the pandemic...
Read MoreOct 24, 2023
Bookmark1. Nearly all participating caregivers listed the following as important influences on...
Read MoreOct 24, 2023
Bookmark1. In surveyed sample, parental hesitancy towards routine vaccination during the pandemic...
Read MoreOct 24, 2023
Bookmark1 .The progression-free survival in berzosertib with topotecan vs topotecan alone was not...
Read MoreOct 21, 2023
Bookmark1. In this cohort study, patients with Medicaid insurance coverage had higher rates of...
Read MoreOct 20, 2023
Bookmark1. One-third of patients with a cancer signal were correctly diagnosed to have cancer. 2....
Read MoreOct 20, 2023
Bookmark1. In this randomized controlled trial, early compared to late blood pressure management...
Read MoreOct 18, 2023
Bookmark1. All-cause mortality after 5 years was similar for patients in the adaptive and...
Read MoreOct 18, 2023
Bookmark1. This cohort study of pediatric solid organ transplant (SOT) patients found that the...
Read MoreOct 17, 2023
Bookmark1. In this cross-sectional study, there was a high-level negative correlation between...
Read More